Table 1.
Channel type | |||||||
---|---|---|---|---|---|---|---|
Malaria induced | CFTR | ClC(1–7) | VRAC | Ca2+-activated | Ligand-gated | Maxi | |
Conductance | 12–18 pS | 5–9 pS | 1–9 pS | 40–50 pS(+Vm) | 1–10 pS | 10–90 pS | 200–400 pS |
I–V | Linear | Linear | Subtype dependent | Outward rectiflication | [Ca2+]dependent | Ligand-type dependeent | Linear |
Permeation | I−>Br−>Cl− | Br−>Cl−>I− | Cl−>Br−>I− | I−>Br−>Cl− | I−>Br−>Cl− | I−>Br−>Cl− | Cl−>acetate |
Inhibitors | NPPB niflumate, glibenclamide, tamoxifen, DPC | NPPB, 9-AC, glibenclamide DPC, DIDS*, suramin* | Subtype dependent but including: DPC, 9-AC | NPPB, DIDS, tamoxifen, niflumate, 1,9-dideoxyforskolin | NPPB, DIDS, niflumate | Ligand-type dependent but including: picrotoxin, cyanotriphenylborate | Phalloidin, DIDS, NPPB, pertussis toxin |
Modulators | Unknown | Phosphorylation by PKA | Subtype dependent but including: cell swelling hyperpolarisation, internal PH, internal [Ca2+], depolarisation | Cell swelling | Internal[Ca2+] | Specific ligands (e.g.GABA, glycine) | Cell swelling, phorbol esters, PKC |
CFTR, cystic fibrosis transmembrane regulator protein; VRAC, volume-regulated anion channel.
Intracellular application